We are committed to developing and delivering cancer therapies that make a meaningful difference for people living with cancer.
Leveraging a Global Pipeline
At EMD Serono, we currently dedicate more that two-thirds of our R&D investment to oncology and immuno-oncology. Through biomarker-driven research, we aim to develop personalized treatments that address hard-to-treat cancers.
We are building a strong pipeline in oncology for an immuno-oncology program that includes potential new medicines in more than 15 difficult-to-treat tumour types with high unmet patient needs.
Ultimately, we aspire to discover and develop diverse treatment options and new approaches to cancer care. Together, we are building a strong position in this emerging area to help those with cancer, live longer, healthier lives.
Work With Us
Our Professionals Make a Difference!
When great minds get together, they inspire each other. Our collaborative culture proves it. By working a better way—sharing ideas, voicing opinions, giving feedback and lending support—we get better results.View All Jobs